Congenital cytomegalovirus (CMV) infections are a leading cause of sensorineural hearing
loss (SNHL) and neurological impairment. Congenital transmission of CMV can occur with …

Cytomegalovirus (CMV) infection is one of the most important infectious complications of
solid-organ transplantation, and is also responsible for serious, life-threatening diseases in …

The precise impact of valganciclovir as preventive therapy for cytomegalovirus (CMV) in
solid organ transplant (SOT) recipients is not fully defined. Data from studies using …

Currently available, potent antiviral agents have proven highly effective for the prevention of
CMV disease during the time that prophylaxis is employed. However, late‐onset CMV …

Cytomegalovirus (CMV) is one of the most significant viral pathogens during pregnancy and
in immunocompromised patients. Antiviral prophylactic strategies are limited by toxicities …

Prolonging cytomegalovirus (CMV) prophylaxis in CMV seronegative recipients of a kidney
from CMV seropositive donor (D+/R–) may reduce the incidence of late infections. We …

Leukemia cells from patients with chronic lymphocytic leukemia (CLL) express a highly
restricted immunoglobulin heavy variable chain (IGHV) repertoire, suggesting that a limited …

Human cytomegalovirus (HCMV) shedding has been extensively investigated in newborns
and in young children, however, much less is known about it in immunocompetent adults …

Background. Cytomegalovirus (CMV) infections after transplantation are commonly treated
using a prophylactic or preemptive regimen with (val) ganciclovir. It remains unclear, which …

Introduction Cytomegalovirus (CMV) is the most frequent infectious complication following
solid organ transplantation. Torque teno viruses (TTV) viremia has been proposed as a …